Huawei debuts WATCH D3 at ESC

Huawei used ESC Congress 2026 in Munich to preview the WATCH D3, a new wrist-based device the company says is designed for blood-pressure management. The company showed the device on August 31 at the European Society of Cardiology’s annual meeting, days before a separate Huawei product launch scheduled for September 2 in Munich. Huawei described the WATCH D3 as its next-generation ambulatory blood pressure monitor and said it expands measurement to more use cases. (prnewswire.com) ### Why did Huawei bring a consumer wearable to a cardiology congress? (prnewswire.com) ESC Congress 2026 ran from August 28 to August 31 in Munich and drew more than 33,800 attendees, according to the European Society of Cardiology. The meeting is one of the field’s largest annual gatherings and this year highlighted new guidelines, trial results and artificial intelligence in cardiology. (escardio.org) Huawei said it used the congress to give what it called an “exclusive sneak peek” of the WATCH D3 before its formal launch. The company framed the appearance as part of a broader effort to connect academic cardiovascular research with consumer health technology. (prnewswire.com) ### What, exactly, is the WATCH D3 supposed to do? Huawei said the WATCH D3 is a wrist-based ambulatory blood pressure recorder. In its preview materials, the company said the device is built to support blood-pressure measurement across more scenarios and to provide readings before and after exercise. (escardio.org) The company also said the WATCH D3 is designed to record blood-pressure data at elevated heart rates and to offer recommendations on exercise intensity. Huawei did not, in the preview release, publish a full specification sheet, price or market-by-market availability. (prnewswire.com) ### How does it fit into Huawei’s existing blood-pressure watch line? Huawei said its work on blood-pressure wearables dates back to 2014, when it entered the sports and health category. The company said it launched its first wrist-based ambulatory blood pressure recorder, the WATCH D, in 2021, and followed with the WATCH D2 in 2024. (prnewswire.com) Huawei’s current global product page for the WATCH D2 says that model includes a mechanical airbag, 24-hour ambulatory blood pressure monitoring, scheduled measurements and on-the-go readings. The page also says the D2 is CE-MDR certified as a medical device and cites European Society of Hypertension practice guidance for ambulatory monitoring intervals and successful reading targets. (prnewswire.com) ### Why are wrist blood-pressure devices getting attention? The WATCH D2 page says ambulatory monitoring can capture average systolic and diastolic readings during the day, at night and across a 24-hour period. That matters because it moves blood-pressure tracking beyond single spot checks and toward repeated measurements across daily activity and sleep. (prnewswire.com) Huawei’s preview for the D3 emphasized that same direction, adding exercise-related readings and broader use scenarios. The company’s presentation at a cardiology meeting suggests it is positioning the device in conversations about patient-generated cardiovascular data, though Huawei did not release independent clinical validation data in the preview announcement. (consumer.huawei.com) ### What is still unknown after the ESC preview? Huawei’s August 31 release said the WATCH D3 would be officially launched at the Huawei Innovative Product Launch in Munich on September 2. The company’s preview did not include final pricing, full technical specifications or a detailed rollout schedule. (consumer.huawei.com) ESC Congress materials say registered delegates can view congress resources, including abstracts, slides and videos, on demand until September 15, with broader presentation access moving to ESC 365 from September 16. Huawei’s next step is the September 2 launch event, where those missing commercial details would typically be disclosed. (escardio.org) (prnewswire.com)